Mereo BioPharma Group plc American Depositary Shares (MREO)
Company News
Pomerantz Law Firm is investigating potential securities fraud by Mereo BioPharma Group and Ultragenyx Pharmaceutical following a significant stock price drop after announcing a delayed final analysis of a Phase 3 clinical study.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Piper Sandler raised the price target for Oracle Corporation (NYSE:ORCL) from $140 to $150. Piper Sandler analyst Brent Bracelin maintained an Overweight rating. Oracle shares fell 0.5% to close at $123.88 on Tuesday. See how other analysts view this stock. Telsey Advisory Group cut the price target for Academy Sports and Outdoors, Inc. (NASDAQ:ASO) from $75 to $65. Telsey Advisory Group analyst Joseph Feldman maintained an Outperform rating. Academy Sports shares fell 3.2% to close at $51.69 on Tuesday. See how other analysts view this stock. Morgan Stanley increased Ciena Corporation (NYSE:CIEN) price target from $53 to $55. Morgan Stanley analyst Meta Marshall upgraded the stock from Equal-Weight to Overweight. Ciena shares rose 0.2% to close at $45.92 on Monday. See how other analysts ...Full story available on Benzinga.com
The heavy selling pressure might have exhausted for MEREO BIOPHARMA (MREO) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Coinbase, Apple, GitLab and other stocks were among the most active on Tuesday.
Use these tips to find penny stocks to buy this Summer The post How to Find Penny Stocks to Buy in Summer 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.